+44 1300 500008Journal of Leukemia : Citations & Metrics Report
Articles published in Journal of Leukemia have been cited by esteemed scholars and scientists all around the world. Journal of Leukemia has got h-index 11, which means every article in Journal of Leukemia has got 11 average citations.
Following are the list of articles that have cited the articles published in Journal of Leukemia.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
60 | 56 | 62 | 62 | 23 | 11 | 8 | 22 | 23 | 48 | 50 | 29 |
Research, Review articles and Editorials |
38 | 44 | 28 | 40 | 2 | 7 | 7 | 14 | 10 | 24 | 27 | 18 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
12 | 12 | 34 | 22 | 21 | 4 | 1 | 8 | 13 | 24 | 23 | 11 |
Conference proceedings |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 28 | 0 | 0 | 0 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
0 | 0 | 0 | 54 | 59 | 64 | 98 | 0 | 74 | 0 | 0 | 0 |
| Journal total citations count | 618 |
| Journal impact factor | 2.11 |
| Journal 5 years impact factor | 3.71 |
| Journal cite score | 3.91 |
| Journal h-index | 11 |
| Journal h-index since 2019 | 8 |
Important citations (462)
5 reasons why scoliosis x-rays are not harmful |
|
kamini j. why imatinib is by far the best drug to treat chronic myeloid leukemia. biochem mol biol lett. 2017;3(2):112. |
|
Umbilical cord preservation- a review |
|
Why imatinib is by far the best drug to treat chronic myeloid leukemia |
|
Economic burden associated with adverse events of special interest in patients with relapsed philadelphia chromosome-negative b-cell acute lymphoblastic leukemia in the united states |
|
Why imatinib is by far the best drug to treat chronic myeloid leukemia? |
|
priyadarshini r, raj gm, shewade dg. status of pharmacogenomics research in india during the last five years. proceedings of the indian national science academy. 2018 apr 2;84(1):195-223. |
|
thakkar dn, palugulla s, selvarajan s, dubashi b. frequency distribution of blmh, xpo5 and hfe gene polymorphisms in the south indian population and their association with hodgkin lymphoma. the international journal of biological markers. 2018 nov;33(4):514-9. |
|
kamini j. why imatinib is by far the best drug to treat chronic myeloid leukemia. biochem mol biol lett. 2017;3(2):112. |
|
Correlation between hasford score with early molecular response in patients with chronic myeloid leukemia in chronic phase treated with imatinib |
|
Association between hasford scoring system and hematologic response in chronic and accelerated phase of chronic myelocytic leukemia patient with imatinib for three months |
|
Why imatinib is by far the best drug to treat chronic myeloid leukemia? |
|
Validations of prognostic scoring systems in iraqi patients with chronic myeloid leukemia in single center |
|
Stratification of chronic myeloid leukemia cancer dataset into risk groups using four machine learning algorithms with minimal loss function |
|
Nee a, lipton jh. update on the management of chronic myeloid leukemia: current best practice and future directions. expert opinion on orphan drugs. 2019 apr 3;7(4):157-69. |
|
selvaraj r. research & reviews: journal of medical and health sciences. |
|
Kumawat bl, sharma cm, saini pk, garg a. central nervous system blast crisis of chronic myeloid leukaemia misdiagnosed as tubercular meningitis. bmj case reports. 2018 jun 12;2018:bcr-2017. |
|
Khodabandeh m, mohammadi m, borhani k, khodabakhsh e. lymphoma infectious mononucleosis by epstein-barr virus: a case report. caspian journal of pediatrics. 2017 sep 15;3(2):257-60. |
|
gv rr. types of cancer and surgery in rats (rattus norvegicus). growth.;91:95. |
|
shatadru b. stem cell research: an overview. biochem mol biol lett. 2017;3(2):121. |
|